Term
400-650 atrial bpm; irregular irregular rhythm; ventricular rate: 120-160 bpm; no identifiable P wave on ECG |
|
Definition
|
|
Term
~300 atrial bpm; regular rhythm; HR 300, 150, 11, 75, or 60 bpm; sawtooth pattern from atrial waves |
|
Definition
|
|
Term
Causes include chronic HTN, mitral stenosis, cardiomyopathy, ischemia, congenital defects, pulmonary HTN, Acute PE |
|
Definition
|
|
Term
causes include ETOH withdrawal, thyrotoxicosis, sepsis, binge drinking, cocaine/amphetamine, excessive caffeine, theophylline or sympathomimetic use |
|
Definition
|
|
Term
Atrial arrhythmia classification: acute |
|
Definition
|
|
Term
atrial arrhythmia classification: paroxysmal |
|
Definition
begins abruptly and converts to sinus rhythm spontaneously within 7 days |
|
|
Term
atrial arrhythmia classification: persistent |
|
Definition
duration longer than 7 days and does NOT terminate spontaneously |
|
|
Term
atrial arrhythmia classification: permanent |
|
Definition
does NOT terminate with pharmacological or electrical conversion attempts |
|
|
Term
atrial arrhythmia classification: recurrent |
|
Definition
|
|
Term
|
Definition
beta blockers, non DHP CCB, digoxin |
|
|
Term
|
Definition
aspirin, warfarin, clopidogrel; dabigatran, rivaroxaban, and apixaban |
|
|
Term
|
Definition
amiodarone, dofetilide, and DCC |
|
|
Term
beta blockers for rate control |
|
Definition
Atenolol; metoprolol; propranolol; esmolol |
|
|
Term
decreases sympathetic stimulation of AV node: slows V nodal conduction, decreases impulses transmitted to the ventricles, decreases ventricular response rate |
|
Definition
|
|
Term
|
Definition
for acute rate control in pts with normal LV fxn; for chronic rate control in pts with normal or impaired LV function; (doses for acute rate control significantly higher than those w/ heart failure); IV is the preferred route for acute management! |
|
|
Term
|
Definition
hypotension, bradycardia, AV block, lipid abnormalities, glucose intolerance, mask hypoglycemia symptoms, heart failure exacerbation, fatigue, fluid retention, depression, bronchospasm, sexual dysfunction |
|
|
Term
CCBs used for rate control |
|
Definition
Diltiazem and Verapamil (non DHP) |
|
|
Term
first line acute for pts with normal LV function; avoid as chronic therapy in pts with impaired LV function; use for less than 24-48 hrs in acute management; IV therapy should be utilized |
|
Definition
Non-DHP Calcium Channel Blockers |
|
|
Term
|
Definition
hypotension, bradycardia, fluid retention, headache, dizziness, flushing, constipation |
|
|
Term
|
Definition
sick sinus syndrome; 2nd or 3rd degree AV block; severe hypotension or cardiogenic shock; afib/aflutter with accessory bypass tract; vtach, co-administration w/ IV beta blocker |
|
|
Term
increases vagal tone to the AV node (vagomimetic activity): prolongs refractory period, decreases number of impulses transmitted to ventricles, decreases ventricular response rate |
|
Definition
|
|
Term
|
Definition
delayed onset of action (not for acute control); ideal for chronic control w/ concomitant heart failure; IV reserved for those unable to tolerate PO; doesn't provide rate control in pts w/ exercise induced tachycardia; decrease dose by 50% for concomitant amiodarone therapy |
|
|
Term
digoxin cardiac toxicities |
|
Definition
ventricular arrhythmias, heart block, bradycardia |
|
|
Term
|
Definition
anorexia, N/V, abdominal pain |
|
|
Term
|
Definition
confusion, agitation, delirium, vision changes |
|
|
Term
risk factors for digoxin toxicity |
|
Definition
hypokalemia, hypomagnesemia, hypercalcemia, hypothyroidis, interacting meds, renal insufficiency |
|
|
Term
digoxin therapeutic trough serum level |
|
Definition
|
|
Term
|
Definition
2nd and 3rd degree heart block (CI); caution when using: amiodarone, diuretics, ketoconazole, quinidine, spironoclactone, verapamil |
|
|
Term
Acute control: if ejection fraction at least 40% and asymptomatic |
|
Definition
non DHP CCB, Beta blocker, digoxin |
|
|
Term
Acute control: if ejection fraction at least 40% and symptomatic |
|
Definition
non DHP CCB; beta blocker |
|
|
Term
Acute control: if ejection fraction < 40% and asymptomatic |
|
Definition
digoxin, diltiazem, amiodarone, beta blocker |
|
|
Term
acute control: if ejection fraction < 40% and symptomatic |
|
Definition
|
|
Term
long term control (after 48 hours) if EF is at least 40% |
|
Definition
non DHP CCB, beta blocker, digoxin |
|
|
Term
long term control (after 48 hours) if EF is < 40% |
|
Definition
|
|
Term
significant decrease in cerebrovascular events; higher doses no more effective and have increased risk of bleeding |
|
Definition
|
|
Term
Reduces the risk of stroke from approximately 5% to 2.4% |
|
Definition
|
|
Term
the standard that attempts to standardize the measurements using an international sensitivity index (ISI) |
|
Definition
International normalized ratio (INR) |
|
|
Term
measure of the thromboplastins responsiveness using a WHO reference |
|
Definition
international sensitivity index (ISI) |
|
|
Term
|
Definition
prophylaxis of VTE, txt of VTE, atrial fibrillation, AMI, valvular heart disease, prosthetic tissue heart valve |
|
|
Term
|
Definition
secondary prevention of AMI, prosthetic mechanical heart valve, patients with + anti-phospholipid antibodies |
|
|
Term
proved to be significantly more effective in reducing stroke compared to warfarin in A. Fib (RE-LY trial) |
|
Definition
|
|
Term
direct thrombin inhibitor; prodrg; not recommended if CrCl < 15 ml/min |
|
Definition
|
|
Term
|
Definition
N/V, constipation, pyrexia, wound secretion, hypotension, insomnia, peripheral edema, anemia, dizziness, diarrhea, HA, elevations in AST/ALT |
|
|
Term
|
Definition
renal function, CBC with differential |
|
|
Term
shown to be noninferior to warfarin for stroke, decreases stroke |
|
Definition
|
|
Term
inhibits factor Xa, reversible, direct and selective; not recommended if CrCl < 15 ml/min |
|
Definition
|
|
Term
|
Definition
itching, bleeding, thrombocytopenia, anemia, AST/ALT/GGT elevation, wound secretion, extremity pain, muscle spasm, syncope, nausea |
|
|
Term
|
Definition
renal function, CBC, hepatic function |
|
|
Term
shown to be superior to warfarin for decreasing stroke |
|
Definition
|
|
Term
inhibits factor Xa, reversible, direct and selective; not recommended if CrCl < 15 ml/min |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
only symptomatic patients receiving optimal rate control |
|
Definition
should receive anti-arrhythmics |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
late and rapid repolarization |
|
|
Term
|
Definition
resting membrane potential (diastolic depolarization) |
|
|
Term
|
Definition
cell receives impulse; rapid Na entry; depolarization |
|
|
Term
|
Definition
Na channels inactivated; partial repolarization |
|
|
Term
|
Definition
calcium re-entry; absolute refractory period |
|
|
Term
Late and Rapid Repolarization |
|
Definition
Rapid potassium exit; relative refractory period |
|
|
Term
Resting membrane potential |
|
Definition
|
|
Term
increase threshold potential, decrease the slop of phase 4, increases the absolute refractory period, shortens the refractoriness |
|
Definition
|
|
Term
Vaughan Williams Classification: Ia |
|
Definition
quinidine, procainamide, disopyramide |
|
|
Term
Vaughan Williams Classification: Ib |
|
Definition
|
|
Term
Vaughan Williams Classification: Ic |
|
Definition
Flecainide and propafenone |
|
|
Term
Vaughan Williams Classification II |
|
Definition
propranolol, esmolol, sotalol |
|
|
Term
Vaughan Williams Classification III |
|
Definition
Dofetilide, sotalol, and amiodarone |
|
|
Term
Vaughan Williams Classification IV |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
bradycardia, hypotension, QT prolongation; Nausea, constipation; phlebitis (IV only) |
|
|
Term
|
Definition
bradycardia, AV blocks, QT prolongation; pulmonary fibrosis; corneal microdeposits, blurred vision, optic neuropathylneuritis; nausea and hepatitis; hypo and hyperthyroidism; bruising, photosensitivity, blue-gray discoloration; myopathy |
|
|
Term
Amiodarone Cautions and CIs |
|
Definition
iodine allergy; second or third degree heart block; bradycardia; prolonged QTc interval; hepatic disease; drug interactions |
|
|
Term
class III antiarrhythmic; significantly effective in restoring normal sinus rhythm and reducing hospitalization |
|
Definition
|
|
Term
|
Definition
cardiac (not common): hypotension, bradycardia, QT prolongation, ventricular arrhythmias; Central: syncope, HA, dizziness; GI: nausea, vomiting diarrhea |
|
|
Term
Dofetilide Cautions and Contraindications |
|
Definition
QTc > 440 msec; CrCl < 20 mL/min; first or second degree heart block; bradycardia |
|
|